<DOC>
	<DOCNO>NCT00322647</DOCNO>
	<brief_summary>1 . To identify reason low patient recruitment number clinical trial cancer research center set ( community set ) order attempt increase accrual rate . 2 . To review screen sheet woman consider participate study Tamoxifen Raloxifene ( STAR ) prevention breast cancer high risk woman University New Mexico Albuquerque 1999 2004</brief_summary>
	<brief_title>Cancer Center Trials : Reasons Low Accrual Rates One Academic Institution Vs . The Community Setting</brief_title>
	<detailed_description>Objective 1 : All new cancer patient see four month period University New Mexico Cancer Research Treatment Center ( UNM CRTC ) ( academic population ) six month-period New Mexico Cancer Care Alliance ( NMCCA ) ( community set ) . A careful screening log keep period research nurse cooperation document 1 ) whether patient see accrued clinical trial , 2 ) available trial patient might possibly eligible , 3 ) reason register clinical trial . Objective 2 : To compare response question entry form woman eligible decline participation participate Hispanic versus non-Hispanic ethnicity , access , copy , analyze risk assessment profile otherwise know entry eligibility form complete woman consider participate study Tamoxifen Raloxifene ( STAR ) . Patterns eligibility criterion risk assessment describe ethnicity woman consider entry chemopreventive randomize trial without use personal identifying data accordance Health Insurance Portability Accountability Act 1996 maintain patient confidentiality</detailed_description>
	<criteria>Women consider participate study Tamoxifen Raloxifene ( STAR ) prevention breast cancer high risk woman University New Mexico Albuquerque 1999 2004 Not specify .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>